Publications in collaboration with researchers from University of Groningen (4)

2021

  1. Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

    American Journal of Hematology

  2. Imetelstat achieves meaningful and durable transfusion independence in high transfusion–Burden patients with lower-risk myelodysplastic syndromes in a phase II study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 48-56

  3. Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

    Leukemia, Vol. 35, Núm. 6, pp. 1745-1750

2020

  1. Luspatercept in patients with lower-risk myelodysplastic syndromes

    New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151